1. Department of Medical Oncology, Franco-British Institute, Levallois-Perret, France;
2. Clinique Sainte-Anne, Strasbourg, France;
3. Department of Medical Oncology, Hopital Saint-Antoine, APHP, Paris, France;
4. Methodology and Quality of Life Unit in Oncology (INSERM UMR 1098), University Hospital of Besançon, Besançon, France;
5. Digestive Oncology, Hopital Duchenne, Boulogne-Sur-Mer, France;
6. Medical Oncology Department, Hôpital Privé des Côtes d'Armor, Plerin, France;
7. Cancerology Institute, Hôpital Privé Jean Mermoz, Lyon, France;
8. Pôle d'Oncologie Médicale, Groupe Hospitalier Public du Sud de l'Oise, Creil, France;
9. Clinique Victor Hugo, Le Mans, France;
10. Medical Oncology Department, Groupe Hospitalier Paris Saint-Joseph, Paris, France;
11. Department of Medical Oncology, CH de Mont-de-Marsan, Hospital Layné, Mont-De-Marsan, France;
12. Medical Oncology Department, Institut Mutualiste Montsouris, Paris, France;
13. CH Annecy-Genevois, Annecy, France;
14. Medical Oncology Department, Lille Metropole Cancer Institute, Villeneuve D'ascq, France;
15. Medical Oncology Department Head, Henri Mondor University Hospital, Créteil, France;
16. Multidisciplinary Group in Oncology (GERCOR), Paris, France;
17. Cancer center, The Chaim Sheba Medical Center, Ramat Gan, Affiliated with the Sackler School of Medicine, Tel Aviv University, Ramat Gan, Israel;
18. Bon Secours Hospital Cork, Cancer Trials Ireland, and University College Cork, Cork, Ireland;
19. Medical Oncology Department, Centre Georges-François Leclerc, University of Bourgogne Franche-Comté, Dijon, France;